Free Trial

Hellenic Dynamics (HELD) Competitors

Hellenic Dynamics logo
GBX 0.0095 0.00 (0.00%)
As of 07/3/2025

HELD vs. HLN, BXP, HIK, HCM, INDV, AMYT, AGY, APH, ANCR, and VLG

Should you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Animalcare Group (ANCR), and Venture Life Group (VLG). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Hellenic Dynamics vs. Its Competitors

Hellenic Dynamics (LON:HELD) and Haleon (LON:HLN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Haleon had 3 more articles in the media than Hellenic Dynamics. MarketBeat recorded 3 mentions for Haleon and 0 mentions for Hellenic Dynamics. Hellenic Dynamics' average media sentiment score of 0.00 beat Haleon's score of -0.74 indicating that Hellenic Dynamics is being referred to more favorably in the media.

Company Overall Sentiment
Hellenic Dynamics Neutral
Haleon Negative

0.1% of Hellenic Dynamics shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 72.9% of Hellenic Dynamics shares are owned by company insiders. Comparatively, 10.7% of Haleon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Haleon has a net margin of 9.66% compared to Hellenic Dynamics' net margin of 0.00%. Haleon's return on equity of 6.54% beat Hellenic Dynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Hellenic DynamicsN/A -364.21% N/A
Haleon 9.66%6.54%4.45%

Haleon has higher revenue and earnings than Hellenic Dynamics. Hellenic Dynamics is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hellenic DynamicsN/AN/A-£5.22M-£3.550.00
Haleon£11.07B3.03£1.07B£11.8931.23

Haleon has a consensus price target of GBX 457, suggesting a potential upside of 23.08%. Given Haleon's stronger consensus rating and higher possible upside, analysts plainly believe Haleon is more favorable than Hellenic Dynamics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hellenic Dynamics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Haleon
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Haleon beats Hellenic Dynamics on 12 of the 14 factors compared between the two stocks.

Get Hellenic Dynamics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HELD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HELD vs. The Competition

MetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£14K£2.14B£5.45B£2.96B
Dividend YieldN/A2.92%5.22%5.02%
P/E Ratio0.004.1627.27147.41
Price / SalesN/A563.67428.46240,143.55
Price / CashN/A10.3526.2127.97
Price / Book0.0111.477.924.54
Net Income-£5.22M£21.15B£3.17B£5.90B
7 Day PerformanceN/A1.54%4.33%1.27%
1 Month PerformanceN/A6.29%2.61%4.62%
1 Year PerformanceN/A2.40%34.78%82.58%

Hellenic Dynamics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HELD
Hellenic Dynamics
N/AGBX 0.01
flat
N/AN/A£14KN/A0.00N/A
HLN
Haleon
1.3311 of 5 stars
GBX 373.10
+0.2%
GBX 457
+22.5%
+16.1%£33.67B£11.07B31.3825,408
BXP
Beximco Pharmaceuticals
N/AGBX 34.26
-2.1%
N/A-9.1%£23.35B£7.08T3.685,500Gap Up
HIK
Hikma Pharmaceuticals
3.9359 of 5 stars
GBX 1,987.94
+0.4%
GBX 2,560
+28.8%
+8.9%£5.51B£3.74B19.519,100
HCM
HUTCHMED
N/AGBX 230
+4.1%
N/A-21.3%£2.50B£771.01M-58.701,760
INDV
Indivior
3.1009 of 5 stars
GBX 1,130
+0.9%
GBX 1,650
+46.0%
-3.3%£1.77B£1.40B-936.931,000
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
AGY
Allergy Therapeutics
N/AGBX 8
flat
N/A+68.4%£393.21M£72.18M-7.71612
APH
Alliance Pharma
2.1129 of 5 stars
GBX 64.70
flat
GBX 6,250
+9,560.0%
N/A£350.32M£183.50M-10.4391,000
ANCR
Animalcare Group
N/AGBX 294
-0.3%
N/A+25.6%£201.57M£84.90M5.48220Gap Down
High Trading Volume
VLG
Venture Life Group
N/AGBX 60.98
+3.3%
N/A+37.5%£77.70M£51.77M103.48165Positive News
Earnings Report
High Trading Volume

Related Companies and Tools


This page (LON:HELD) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners